[Form 4] Wesco International Inc. Insider Trading Activity
Rhea-AI Filing Summary
Wesco International Inc. (WCC) reporting person David S. Schulz, EVP & CFO, reported multiple transactions on 08/26/2025–08/27/2025. He exercised 27,507 Stock Appreciation Rights at an exercise price of $48.32, resulting in acquisition of 27,507 common shares. Following that acquisition his reported beneficial ownership rose to 137,883.2917 shares. On 08/26–08/27/2025 he disposed of a series of common shares in several transactions: 5,869 shares, 9,411 shares, 9,389 shares, 2,738 shares and 100 shares at weighted average sale prices in the $224.38–$226.63 range, reducing his reported holdings to 110,376.2917 shares.
Positive
- Exercise of SARs resulted in acquisition of 27,507 common shares at an exercise price of $48.32
- Reported beneficial ownership remained substantial at 110,376.2917 shares after transactions
Negative
- Substantial disposals totaling 27,507 common shares across 08/26–08/27/2025 at weighted average prices in the $224–$226 range
- No disclosure of percentage ownership or context about total outstanding shares, limiting assessment of materiality
Insights
TL;DR: Insider exercised SARs and sold portions of holdings in multiple transactions, leaving substantial net ownership.
The reporting shows an exercise of 27,507 Stock Appreciation Rights at an exercise price of $48.32, which produced an equal number of common shares. Concurrently, Schulz executed multiple sales totaling 27,507 common shares across 08/26–08/27/2025 at weighted average prices around $224–$226, bringing reported beneficial ownership to 110,376.2917 shares. The pattern—exercise followed by systematic sales—appears consistent with exercising compensation awards and monetizing a portion of the resulting shares rather than an isolated large block sale. Transactions are sizeable in absolute terms but the form contains no context on percentage ownership or insider's overall stake relative to outstanding shares.
TL;DR: Transactions comply with disclosure norms; exercise vesting schedule is disclosed.
The filing discloses the exercisability schedule for the Stock Appreciation Rights, noting three equal annual installments from the 02/13/2020 grant date, and provides weighted average sale price ranges for the disposals. The report is properly signed by an attorney-in-fact and identifies the reporting person as EVP & CFO. There is no indication of Rule 10b5-1 plan reliance or any amendment to prior filings in this document.